Literature DB >> 21701506

Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt.

Xin Li1, Haihua Yang, Jianyu Liu, Micheal D Schmidt, Tianyan Gao.   

Abstract

PHLPP1 (PH domain leucine-rich-repeats protein phosphatase) is a Ser/Thr protein phosphatase that acts as a tumour suppressor by negatively regulating Akt. Here, we show that PHLPP1 is recruited to the cell membrane by binding to a scaffolding protein: Scribble. Knockdown of Scribble (Scrib) results in redistribution of PHLPP1 from the membrane to the cytoplasm and an increase in Akt phosphorylation, whereas overexpression of Scrib has the opposite effect. Furthermore, PHLPP1-dependent inhibition of cell proliferation is facilitated by the formation of a Scrib, PHLPP1 and Akt trimeric complex. Thus, our findings identify a functional interaction between PHLPP1 and Scrib in negatively regulating Akt signalling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21701506      PMCID: PMC3147256          DOI: 10.1038/embor.2011.106

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  18 in total

1.  Junctional recruitment of mammalian Scribble relies on E-cadherin engagement.

Authors:  Christel Navarro; Sébastien Nola; Stéphane Audebert; Marie-Josée Santoni; Jean-Pierre Arsanto; Christophe Ginestier; Sylvie Marchetto; Jocelyne Jacquemier; Daniel Isnardon; André Le Bivic; Daniel Birnbaum; Jean-Paul Borg
Journal:  Oncogene       Date:  2005-06-23       Impact factor: 9.867

2.  Scribble associates with two polarity proteins, Lgl2 and Vangl2, via distinct molecular domains.

Authors:  Laura M Kallay; Allison McNickle; Patrick J Brennwald; Ann L Hubbard; Lelita T Braiterman
Journal:  J Cell Biochem       Date:  2006-10-01       Impact factor: 4.429

3.  Localization of apical epithelial determinants by the basolateral PDZ protein Scribble.

Authors:  D Bilder; N Perrimon
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

4.  PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.

Authors:  John Brognard; Emma Sierecki; Tianyan Gao; Alexandra C Newton
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

5.  Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors.

Authors:  D Bilder; M Li; N Perrimon
Journal:  Science       Date:  2000-07-07       Impact factor: 47.728

Review 6.  Mechanism of activation and function of protein kinase B.

Authors:  D R Alessi; P Cohen
Journal:  Curr Opin Genet Dev       Date:  1998-02       Impact factor: 5.578

7.  Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression.

Authors:  Daniela Gardiol; Alberto Zacchi; Francesca Petrera; Giorgio Stanta; Lawrence Banks
Journal:  Int J Cancer       Date:  2006-09-15       Impact factor: 7.396

Review 8.  Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors.

Authors:  David Bilder
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

Review 9.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

10.  Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix.

Authors:  S Nakagawa; T Yano; K Nakagawa; S Takizawa; Y Suzuki; T Yasugi; J M Huibregtse; Y Taketani
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

View more
  33 in total

1.  Pleckstrin homology domain leucine-rich repeat protein phosphatase (PHLPP): a new player in cell signaling.

Authors:  Noel A Warfel; Alexandra C Newton
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

2.  Suppression of survival signalling pathways by the phosphatase PHLPP.

Authors:  Audrey K O'Neill; Matthew J Niederst; Alexandra C Newton
Journal:  FEBS J       Date:  2012-03-16       Impact factor: 5.542

Review 3.  Turning off AKT: PHLPP as a drug target.

Authors:  Alexandra C Newton; Lloyd C Trotman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

Review 4.  Polarity scaffolds signaling in epithelial cell permeability.

Authors:  Lauren F O'Leary; Andrea M Tomko; Denis J Dupré
Journal:  Inflamm Res       Date:  2021-03-15       Impact factor: 4.575

5.  Antibody crossreactivity between the tumour suppressor PHLPP1 and the proto-oncogene β-catenin.

Authors:  Viola H Lobert; Jarle Bruun; Hilde Abrahamsen; Ragnhild A Lothe; Harald Stenmark; Matthias Kolberg; Coen Campsteijn
Journal:  EMBO Rep       Date:  2012-12-11       Impact factor: 8.807

6.  FANCI is a negative regulator of Akt activation.

Authors:  Xiaoshan Zhang; Xiaoyan Lu; Shamima Akhter; Maria-Magdalena Georgescu; Randy J Legerski
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

7.  Viral PDZ Binding Motifs Influence Cell Behavior Through the Interaction with Cellular Proteins Containing PDZ Domains.

Authors:  Carlos Castaño-Rodriguez; Jose M Honrubia; Javier Gutiérrez-Álvarez; Isabel Sola; Luis Enjuanes
Journal:  Methods Mol Biol       Date:  2021

Review 8.  The Mammalian Blood-Testis Barrier: Its Biology and Regulation.

Authors:  Dolores D Mruk; C Yan Cheng
Journal:  Endocr Rev       Date:  2015-09-10       Impact factor: 19.871

9.  Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.

Authors:  Xiaopeng Xiong; Xin Li; Yang-An Wen; Tianyan Gao
Journal:  J Biol Chem       Date:  2016-10-19       Impact factor: 5.157

10.  Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein.

Authors:  Mathew A Cherian; Hicham H Baydoun; Jacob Al-Saleem; Nikoloz Shkriabai; Mamuka Kvaratskhelia; Patrick Green; Lee Ratner
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.